900 results on '"Kelly, Kara"'
Search Results
52. Pediatric Lymphomas and Histiocytic Disorders of Childhood
53. Glutamine for the treatment of vincristine-induced neuropathy in children and adolescents with cancer
54. Feasibility of baseline neurocognitive assessment using Cogstate during the first month of therapy for childhood leukemia
55. Lymphomas
56. Potential Role of Complementary and Alternative Medicine in Pediatric Oncology: The Future of CAM Research – Addressing the 'Effectiveness Gaps'
57. Additional file 4 of Symptom management care pathway adaptation process and specific adaptation decisions
58. Additional file 3 of Symptom management care pathway adaptation process and specific adaptation decisions
59. Additional file 1 of Symptom management care pathway adaptation process and specific adaptation decisions
60. Additional file 2 of Symptom management care pathway adaptation process and specific adaptation decisions
61. Additional file 5 of Symptom management care pathway adaptation process and specific adaptation decisions
62. Understanding social network support, composition, and structure among cancer caregivers
63. International Prognostic Score for Nodular Lymphocyte-Predominant Hodgkin Lymphoma
64. Abstract B096: Food insecurity and receipt of Supplemental Nutrition Assistance Program (SNAP) benefits among income-eligible US pediatric acute lymphoblastic leukemia patients enrolled on a multi-center clinical trial
65. Nivolumab, Brentuximab Vedotin, +/- Bendamustine For R/R Hodgkin Lymphoma in Children, Adolescents, and Young Adults
66. Peripheral Neuropathy in Children with High Risk Hodgkin Lymphoma (HL): The Role of Protocol-Stipulated Dose Modification in the Children's Oncology Group (COG) AHOD1331 Study
67. Evaluating CHIPS in Pediatric High Risk Hodgkin Lymphoma Treated on AHOD1331
68. Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin’s Lymphoma
69. Obstetrical Care in Survivors of Childhood Cancer: Utilization of Unique Linked Databases to Further Refine Consensus Guidelines
70. Malignant Lymphomas in Childhood
71. Contributors
72. Health Status and Health-related Quality of Life Measurement in Pediatric Cancer Clinical Trials: An Examination of the DFCI 00-01 Acute Lymphoblastic Leukemia Protocol
73. Acupressure bands do not improve chemotherapy‐induced nausea control in pediatric patients receiving highly emetogenic chemotherapy: A single‐blinded, randomized controlled trial
74. Children's Oncology Group's 2023 blueprint for research: Hodgkin lymphoma.
75. Oral Mercaptopurine Adherence in Pediatric Acute Lymphoblastic Leukemia: A Survey Study From the Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium
76. T087: Brentuximab vedotin (Bv) Demonstrates Superior Event-Free Survival in Pediatric High-Risk Hodgkin Lymphoma
77. P086: Advancing Pediatric Hodgkin Lymphoma Research Through NODAL
78. P090: Staging of Lung Lesions Survey Demonstrates Continued Need for Harmonization
79. Post-Traumatic Stress Symptoms in Adolescent Hodgkin Lymphoma Survivors: A Report from Children's Oncology Group AHOD0031
80. Feasibility of oncology clinical trial‐embedded evaluation of social determinants of health
81. Genetic loss of SH2B3 in acute lymphoblastic leukemia
82. Outcomes in adolescents and young adults with Hodgkin lymphoma treated on US cooperative group protocols: An adult intergroup (E2496) and Childrenʼs Oncology Group (COG AHOD0031) comparative analysis
83. Post-Traumatic Stress Symptoms in Adolescent Hodgkin Lymphoma Survivors: A Report from Children's Oncology Group AHOD0031.
84. An initial investigation of using smartphone‐enabled micro‐temporal data collection to increase acceptability, feasibility, and validity of research on cancer caregiving
85. Feasibility of Serial Neurocognitive Assessment Using Cogstate During and After Therapy for Childhood Leukemia
86. Brentuximab vedotin and association with event-free survival (EFS) in children with newly diagnosed high-risk Hodgkin lymphoma (HL): A report from the Children's Oncology Group phase 3 study AHOD1331 (NCT 02166463).
87. The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: A report from the Dana-Farber Cancer Institute ALL Consortium
88. BEACOPP chemotherapy is a highly effective regimen in children and adolescents with high-risk Hodgkin lymphoma: a report from the Children's Oncology Group
89. Feasibility of oncology clinical trial-embedded evaluation of social determinants of health
90. Practice patterns for the management of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL): an international survey by the Global NLPHL One Working Group (GLOW)
91. Durable remission for four pediatric patients with high‐risk relapsed classical Hodgkin lymphoma treated with brentuximab vedotin plus gemcitabine but without autologous stem cell transplantation: A report from the Children's Oncology Group
92. Predictors of thrombosis in children receiving therapy for acute lymphoblastic leukemia: Results from Dana‐Farber Cancer Institute ALL Consortium trial 05‐001
93. Patterns of Initial Relapse from a Phase 3 Study of Response-Based Therapy for High-Risk Hodgkin Lymphoma (AHOD0831): A Report from the Children's Oncology Group
94. Behavioral parenting skills as a novel target for improving medication adherence in young children: Feasibility and acceptability of the CareMeds intervention
95. Contributors
96. Pediatric Hodgkin's Lymphoma
97. The Antioxidant Debate
98. The Evolution of Children's Oncology Group Hodgkin Lymphoma Trials: Predicted Impact on Late Cardiac Toxicity
99. Performance of Next Generation Sequencing for Minimal Residual Disease Detection for Pediatric Patients with Acute Lymphoblastic Leukemia: Results from the Prospective Clinical Trial DFCI 16-001
100. Impact of Age, Body Surface Area, and Body Mass Index on Pegaspargase Toxicity and Pharmacokinetics: A Report from the DFCI ALL Consortium
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.